Survival of skin cancer stem cells requires the Ezh2 polycomb group protein

Gautam Adhikary, Daniel Grun, Sivaprakasam Balasubramanian, Candace Kerr, Jennifer M. Huang, Richard L. Eckert

Research output: Contribution to journalArticlepeer-review

Abstract

Polycomb group proteins, including Ezh2, are important candidate stem cell maintenance proteins in epidermal squamous cell carcinoma. We previously showed that epidermal cancer stem cells (ECS cells) represent a minority of cells in tumors, are highly enriched in Ezh2 and drive aggressive tumor formation. We now show that Ezh2 is required for ECS cell survival, migration, invasion and tumor formation and that this is associated with increased histone H3 trimethylation on lysine 27, a mark of Ezh2 action. We also show that Ezh2 knockdown or treatment with Ezh2 inhibitors, GSK126 or EPZ-6438, reduces Ezh2 level and activity, leading to reduced ECS cell spheroid formation, migration, invasion and tumor growth. These studies indicate that epidermal squamous cell carcinoma cells contain a subpopulation of cancer stem (tumor-initiating) cells that are enriched in Ezh2, that Ezh2 is required for optimal ECS cell survival and tumor formation and that treatment with Ezh2 inhibitors may be a strategy for reducing ECS cell survival and suppressing tumor formation.

Original languageEnglish (US)
Pages (from-to)800-810
Number of pages11
JournalCarcinogenesis
Volume36
Issue number7
DOIs
StatePublished - 2015
Externally publishedYes

ASJC Scopus subject areas

  • Cancer Research
  • Medicine(all)

Fingerprint Dive into the research topics of 'Survival of skin cancer stem cells requires the Ezh2 polycomb group protein'. Together they form a unique fingerprint.

Cite this